J-ALEX trial
E1995245
UNEXPLORED
The J-ALEX trial was a phase III clinical study comparing alectinib with crizotinib as first-line treatment in patients with ALK-positive non-small cell lung cancer in Japan.
All labels observed (1)
| Label | Occurrences |
|---|---|
| J-ALEX trial canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.